Murine models define the role of TGF-beta as a master regulator of immune cell function (Q33857591)

29 July 2017

1 reference

title

Murine models define the role of TGF-beta as a master regulator of immune cell function (English)

1 reference

29 July 2017

0 references

1 reference

Letterio JJ

1

1 reference

PubMed ID

10708955

29 July 2017

language of work or name

1 reference

1 March 2000

1 reference

Cytokine and Growth Factor Reviews

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

1-2

1 reference

29 July 2017

81-87

1 reference

Purification and initial characterization of a type beta transforming growth factor from human placenta

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Autocrine secretion--10 years later

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factor-beta is a potent negative regulator of human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Biology of TGF-beta in knockout and transgenic mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Tumor suppressor activity of the TGF-beta pathway in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Mutations in the SMAD4/DPC4 gene in juvenile polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Smad3 mutant mice develop metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900031-3

7 January 2021

10.1016/S1359-6101(99)00031-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10708955